Cooper's (CBE) CooperVision Said to Have Addressed FDA Volations
Tweet Send to a FriendGet Alerts CBE Hot Sheet
Up)
Trade CBE Now!
CooperVision, Inc., a subsidiary of The Cooper Companies, Inc. (NYSE: CBE), received a letter from the United States Food and Drug Administration regarding the Warning Letter issued on December 5, 2011. The FDA reported that it has completed an evaluation of the Company’s corrective actions, and it appears the Company has addressed the violations contained in the letter.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Janssen Pharma (JNJ) Plans Slew of Filing, Extension Submissions by FY17
- LRAD Corp, (LRAD), Iroquois Master Fund Enter Settlement
- Nokia Siemens, Intel (INTC) Enter Liquid Applications MoU (NOK) (SI)
Create E-mail Alert Related Categories
Corporate News, FDA
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
